GC
Globeflex Capital L P
13F filer · CIK 0000921531Reported Aug 12, 2026
Net seller this quarter
13F portfolio value$783MU.S. long equity reported on 13F
Positions39369 new · 62 closed
Net flow last quarter-$23.8MBuys minus sells
Top 10 positions weight18.1%Concentration
Holdings
13F · last 4 quarters freeScroll for earlier quarters
| Company | Value | % of portfolio | % of company | POSITION CHANGE qoq % | First reported |
|---|---|---|---|---|---|
| Q2 2026Reported Aug 12, 2026393 positions | |||||
| $23.3M | 2.98% | 0.37% | -4.8% | Q1 2025 | |
| $15.6M | 2.00% | 0.62% | 0.0% | Q1 2024 | |
| $13.9M | 1.77% | 0.10% | -2.2% | Q3 2016 | |
| $13.6M | 1.74% | 0.21% | Not reported | Q2 2013 | |
| $13.2M | 1.69% | 0.05% | -2.9% | Q1 2025 | |
| $13M | 1.66% | 0.04% | -16.3% | Q4 2017 | |
| $12.9M | 1.65% | 0.29% | Not reported | Q3 2025 | |
| $12.7M | 1.62% | 0.15% | -4.5% | Q2 2013 | |
| $11.9M | 1.52% | 0.17% | -9.2% | Q3 2014 | |
| $11.4M | 1.46% | Not reported | +15.0% | Q3 2025 | |
| $10.7M | 1.37% | 0.05% | +13.7% | Q1 2017 | |
| $10.6M | 1.35% | 0.14% | -0.9% | Q3 2016 | |
| $10.3M | 1.32% | 0.11% | -8.7% | Q3 2014 | |
| $10.1M | 1.29% | 0.06% | Not reported | Q1 2016 | |
| $9.7M | 1.24% | 0.06% | +0.2% | Q2 2013 | |
| $9.55M | 1.22% | 0.57% | +0.2% | Q4 2024 | |
| $8.99M | 1.15% | 0.48% | +29.0% | Q4 2017 | |
| $8.79M | 1.12% | 0.44% | -1.9% | Q3 2022 | |
| $8.5M | 1.09% | 0.01% | -13.1% | Q2 2013 | |
| $8.23M | 1.05% | 0.35% | +0.2% | Q1 2018 | |
| $7.88M | 1.01% | 0.13% | -9.5% | Q4 2024 | |
| $7.42M | 0.95% | 0.13% | -11.9% | Q4 2017 | |
| $7.11M | 0.91% | 0.13% | +0.4% | Q4 2019 | |
| $6.98M | 0.89% | 0.34% | -3.1% | Q4 2019 | |
| $6.83M | 0.87% | 0.05% | -0.3% | Q2 2020 | |
| $6.76M | 0.86% | 0.04% | -0.2% | Q2 2013 | |
| $6.7M | 0.86% | 0.01% | Not reported | Q2 2013 | |
| $6.65M | 0.85% | 0.39% | Not reported | Q1 2017 | |
| $6.62M | 0.85% | 0.98% | Not reported | Q4 2016 | |
| $6.57M | 0.84% | 0.39% | Not reported | Q3 2016 | |
| $6.51M | 0.83% | 0.25% | +2.3% | Q2 2023 | |
| $6.2M | 0.79% | Not reported | -6.4% | Q2 2013 | |
| $6.04M | 0.77% | 0.08% | +1189.9% | Q2 2019 | |
| $5.99M | 0.76% | 0.12% | +31.0% | Q1 2026 | |
| $5.97M | 0.76% | Not reported | Not reported | Q3 2023 | |
| $5.94M | 0.76% | 0.27% | -9.9% | Q1 2017 | |
| $5.94M | 0.76% | 0.25% | +59.0% | Q3 2014 | |
| $5.81M | 0.74% | 0.04% | -15.1% | Q3 2018 | |
| $5.72M | 0.73% | 0.04% | -0.5% | Q1 2023 | |
| $5.67M | 0.72% | 0.02% | Not reported | Q3 2021 | |
| $5.56M | 0.71% | 0.13% | Not reported | Q3 2014 | |
| $5.51M | 0.70% | 0.03% | +14.1% | Q3 2019 | |
| $5.42M | 0.69% | 0.04% | -0.1% | Q1 2017 | |
| $5.4M | 0.69% | 0.54% | Not reported | Q3 2014 | |
| $5.28M | 0.67% | 0.59% | +0.1% | Q2 2024 | |
| $5.19M | 0.66% | 0.53% | +0.8% | Q2 2013 | |
| $5.15M | 0.66% | 0.27% | Not reported | Q1 2024 | |
| $5.09M | 0.65% | 0.13% | -5.1% | Q2 2013 | |
| $4.94M | 0.63% | 0.03% | Not reported | Q3 2016 | |
| $4.9M | 0.63% | 0.08% | +43.0% | Q2 2020 | |
| Q1 2026Reported May 13, 2026386 positions | |||||
| $21.6M | 3.26% | 0.39% | Not reported | Q1 2025 | |
| $11.6M | 1.76% | 0.30% | -2.4% | Q1 2017 | |
| $11.2M | 1.70% | 0.63% | Not reported | Q1 2024 | |
| $11.2M | 1.69% | 0.10% | Not reported | Q3 2016 | |
| CPCPRXCatalyst Pharmaceuticals, Inc. | $11.2M | 1.69% | 0.37% | +54.2% | Q4 2020 |
| $10.4M | 1.57% | 0.14% | Not reported | Q3 2016 | |
| $10.2M | 1.55% | 0.06% | Not reported | Q1 2016 | |
| $10.1M | 1.52% | 0.05% | -4.1% | Q1 2025 | |
| $9.92M | 1.50% | 0.21% | Not reported | Q2 2013 | |
| $9.85M | 1.49% | 0.16% | -2.0% | Q2 2013 | |
| $9.46M | 1.43% | 0.29% | -1.6% | Q3 2025 | |
| $9.17M | 1.39% | 0.03% | Not reported | Q3 2025 | |
| $9.08M | 1.37% | 0.12% | +4059.9% | Q3 2014 | |
| $8.03M | 1.22% | 0.05% | -3.8% | Q4 2017 | |
| $8.02M | 1.21% | 0.39% | Not reported | Q1 2017 | |
| $7.97M | 1.21% | Not reported | Not reported | Q2 2013 | |
| $7.82M | 1.18% | 0.06% | +40.7% | Q2 2013 | |
| $7.24M | 1.10% | 0.35% | +5.8% | Q1 2018 | |
| $6.93M | 1.05% | 0.04% | -7.8% | Q3 2023 | |
| $6.9M | 1.04% | 0.04% | Not reported | Q1 2017 | |
| $6.84M | 1.03% | 0.04% | -25.2% | Q2 2013 | |
| $6.81M | 1.03% | 0.01% | +3.6% | Q2 2013 | |
| $6.74M | 1.02% | 0.45% | -14.5% | Q3 2022 | |
| $6.73M | 1.02% | 0.39% | Not reported | Q3 2016 | |
| $6.54M | 0.99% | Not reported | -4.1% | Q2 2025 | |
| $6.47M | 0.98% | 0.37% | +52.0% | Q4 2017 | |
| $6.44M | 0.97% | 0.19% | -3.1% | Q3 2014 | |
| $6.37M | 0.96% | 0.14% | +44.1% | Q4 2024 | |
| $6.2M | 0.94% | 0.05% | -6.4% | Q3 2018 | |
| $5.94M | 0.90% | 0.04% | Not reported | Q1 2017 | |
| $5.91M | 0.89% | 0.57% | +16.4% | Q4 2024 | |
| $5.89M | 0.89% | 1.18% | Not reported | Q1 2016 | |
| $5.81M | 0.88% | 0.98% | -7.9% | Q4 2016 | |
| $5.71M | 0.86% | 0.13% | -4.1% | Q2 2013 | |
| $5.56M | 0.84% | 0.05% | Not reported | Q2 2020 | |
| $5.27M | 0.80% | 0.24% | -17.9% | Q2 2023 | |
| $5.21M | 0.79% | 0.04% | -4.3% | Q3 2018 | |
| $5.17M | 0.78% | 0.13% | -34.9% | Q3 2014 | |
| $5.01M | 0.76% | 0.35% | Not reported | Q4 2019 | |
| $4.9M | 0.74% | 0.08% | Not reported | Q4 2013 | |
| $4.84M | 0.73% | 0.04% | +391.1% | Q1 2023 | |
| $4.82M | 0.73% | 0.13% | Not reported | Q4 2019 | |
| $4.64M | 0.70% | 0.54% | Not reported | Q3 2014 | |
| $4.63M | 0.70% | Not reported | +76.0% | Q3 2025 | |
| $4.5M | 0.68% | Not reported | Not reported | Q3 2023 | |
| $4.3M | 0.65% | 0.07% | +31.4% | Q1 2024 | |
| $4.26M | 0.64% | 0.31% | Not reported | Q4 2022 | |
| $4.24M | 0.64% | 0.68% | +2033.2% | Q4 2025 | |
| $4.16M | 0.63% | 0.36% | Not reported | Q4 2019 | |
| $4.14M | 0.63% | 0.14% | -20.6% | Q4 2017 | |
| Q4 2025Reported Feb 11, 2026398 positions | |||||
| $18.2M | 2.79% | 0.39% | +17.5% | Q1 2025 | |
| $11.4M | 1.75% | 0.10% | Not reported | Q3 2016 | |
| $10.5M | 1.61% | 0.21% | +5.8% | Q2 2013 | |
| $9.71M | 1.49% | Not reported | Not reported | Q2 2013 | |
| $9.62M | 1.47% | 0.06% | Not reported | Q2 2013 | |
| $9.56M | 1.46% | 0.34% | Not reported | Q3 2024 | |
| $9.33M | 1.43% | 1.19% | +0.1% | Q1 2016 | |
| $9.3M | 1.42% | 0.62% | Not reported | Q1 2024 | |
| $8.52M | 1.30% | 0.14% | Not reported | Q3 2016 | |
| $8.49M | 1.30% | 0.16% | +1.0% | Q2 2013 | |
| $8.27M | 1.27% | 0.05% | Not reported | Q1 2025 | |
| $8.27M | 1.27% | 0.30% | +2.8% | Q3 2025 | |
| $8.04M | 1.23% | 0.31% | -7.0% | Q1 2017 | |
| $8.01M | 1.23% | 0.06% | -13.8% | Q1 2016 | |
| $7.93M | 1.21% | 1.55% | -5.1% | Q2 2022 | |
| $7.76M | 1.19% | 0.03% | -5.1% | Q3 2025 | |
| $7.75M | 1.19% | 0.05% | -1.9% | Q3 2018 | |
| $7.56M | 1.16% | 0.49% | +65.0% | Q4 2024 | |
| $7.49M | 1.15% | 0.39% | Not reported | Q1 2017 | |
| $7M | 1.07% | 1.08% | Not reported | Q4 2016 | |
| $6.89M | 1.05% | 0.19% | Not reported | Q3 2014 | |
| CPCPRXCatalyst Pharmaceuticals, Inc. | $6.82M | 1.04% | 0.24% | +0.5% | Q4 2020 |
| $6.78M | 1.04% | 0.03% | -20.8% | Q2 2013 | |
| $6.5M | 0.99% | 0.33% | +24.1% | Q1 2018 | |
| $6.15M | 0.94% | 0.08% | Not reported | Q4 2013 | |
| $6.15M | 0.94% | 0.05% | +6.9% | Q2 2020 | |
| $6.11M | 0.93% | 0.52% | +8.8% | Q3 2022 | |
| $5.99M | 0.92% | 0.39% | Not reported | Q3 2016 | |
| $5.86M | 0.90% | Not reported | +5.4% | Q2 2025 | |
| $5.84M | 0.89% | 0.09% | +23.6% | Q2 2025 | |
| $5.8M | 0.89% | 0.05% | +10.5% | Q4 2017 | |
| $5.61M | 0.86% | 0.35% | Not reported | Q4 2019 | |
| $5.43M | 0.83% | 0.05% | -7.4% | Q1 2025 | |
| $5.43M | 0.83% | 0.05% | -7.0% | Q3 2023 | |
| $5.34M | 0.82% | 0.21% | Not reported | Q4 2023 | |
| $5.29M | 0.81% | 0.04% | +545.4% | Q1 2017 | |
| $5.27M | 0.81% | 0.13% | Not reported | Q4 2019 | |
| $5.16M | 0.79% | 0.14% | -6.1% | Q2 2013 | |
| $5.14M | 0.79% | 0.04% | +3021.1% | Q2 2013 | |
| $5.04M | 0.77% | 0.30% | -12.0% | Q2 2023 | |
| $4.93M | 0.76% | 0.12% | Not reported | Q3 2019 | |
| $4.72M | 0.72% | 0.59% | -14.0% | Q2 2024 | |
| $4.61M | 0.71% | 0.19% | +269.6% | Q3 2014 | |
| $4.53M | 0.69% | 0.04% | Not reported | Q2 2013 | |
| $4.5M | 0.69% | 0.18% | Not reported | Q4 2017 | |
| $4.45M | 0.68% | 0.01% | +36.7% | Q2 2013 | |
| $4.38M | 0.67% | 0.06% | -15.9% | Q1 2024 | |
| $4.37M | 0.67% | 0.25% | +80.9% | Q4 2017 | |
| $4.28M | 0.65% | 0.85% | +59.2% | Q4 2024 | |
| $4.22M | 0.65% | Not reported | +36.9% | Q2 2024 | |
| Q3 2025Reported Nov 12, 2025403 positions | |||||
| $14.7M | 2.27% | 0.32% | Not reported | Q1 2025 | |
| $12.4M | 1.91% | 0.57% | Not reported | Q4 2022 | |
| $11.4M | 1.75% | 0.62% | +40.2% | Q1 2024 | |
| $10.8M | 1.66% | 0.10% | -72.1% | Q3 2016 | |
| $9.86M | 1.52% | 0.34% | -45.4% | Q3 2024 | |
| $9.83M | 1.51% | 0.05% | Not reported | Q2 2013 | |
| $9.8M | 1.51% | 0.20% | Not reported | Q2 2013 | |
| $9.37M | 1.44% | 0.34% | +1.8% | Q1 2017 | |
| $9.11M | 1.40% | Not reported | Not reported | Q2 2013 | |
| $9.01M | 1.39% | 0.14% | -28.6% | Q3 2016 | |
| $8.87M | 1.37% | 1.63% | Not reported | Q2 2022 | |
| $7.59M | 1.17% | 0.03% | New | Q3 2025 | |
| $7.37M | 1.13% | 0.04% | -70.0% | Q2 2013 | |
| $7.23M | 1.11% | 0.05% | -4.5% | Q3 2018 | |
| $7.05M | 1.09% | 0.29% | New | Q3 2025 | |
| $6.74M | 1.04% | 0.19% | +2.0% | Q3 2014 | |
| $6.65M | 1.02% | 0.06% | -2.7% | Q1 2025 | |
| $6.62M | 1.02% | 0.12% | Not reported | Q3 2019 | |
| $6.47M | 1.00% | 0.15% | -41.4% | Q2 2013 | |
| $6.38M | 0.98% | Not reported | +3.2% | Q2 2025 | |
| $6.35M | 0.98% | 0.87% | +1.8% | Q2 2013 | |
| $6.25M | 0.96% | 0.07% | Not reported | Q1 2016 | |
| $6.21M | 0.96% | 0.33% | -4.8% | Q2 2023 | |
| $6.17M | 0.95% | 1.21% | +29.9% | Q1 2016 | |
| $6.14M | 0.95% | 0.13% | Not reported | Q4 2019 | |
| $5.88M | 0.91% | 0.15% | Not reported | Q2 2013 | |
| $5.86M | 0.90% | 0.05% | +39.8% | Q1 2025 | |
| $5.82M | 0.90% | 0.34% | +36.2% | Q4 2019 | |
| CPCPRXCatalyst Pharmaceuticals, Inc. | $5.73M | 0.88% | 0.24% | -2.5% | Q4 2020 |
| $5.65M | 0.87% | 0.39% | Not reported | Q1 2017 | |
| $5.51M | 0.85% | 0.08% | -44.3% | Q4 2013 | |
| $5.51M | 0.85% | 0.39% | Not reported | Q3 2016 | |
| $5.47M | 0.84% | 0.18% | +28.7% | Q4 2017 | |
| $5.43M | 0.84% | Not reported | Not reported | Q2 2025 | |
| $5.42M | 0.84% | 0.04% | -75.3% | Q2 2019 | |
| $5.36M | 0.83% | 0.07% | Not reported | Q1 2024 | |
| $5.22M | 0.80% | 0.07% | +2801.6% | Q2 2025 | |
| $5.2M | 0.80% | 0.08% | +7.5% | Q2 2019 | |
| $5.17M | 0.80% | 0.05% | -84.1% | Q2 2020 | |
| $5.03M | 0.77% | 0.69% | -2.0% | Q2 2024 | |
| $5.01M | 0.77% | 0.21% | Not reported | Q4 2023 | |
| $4.98M | 0.77% | 0.05% | -49.8% | Q3 2016 | |
| $4.96M | 0.76% | 0.05% | Not reported | Q3 2023 | |
| $4.93M | 0.76% | 0.05% | -2.7% | Q3 2018 | |
| $4.89M | 0.75% | 0.52% | Not reported | Q2 2023 | |
| $4.67M | 0.72% | 0.04% | Not reported | Q4 2013 | |
| $4.51M | 0.69% | 0.24% | Not reported | Q1 2018 | |
| $4.31M | 0.66% | 0.45% | Not reported | Q3 2022 | |
| $4.18M | 0.64% | 0.57% | Not reported | Q3 2016 | |
| $4.16M | 0.64% | 0.10% | Not reported | Q4 2024 | |
Premium opens every quarter this fund has filed